Results 151 to 160 of about 471,786 (305)
[Multilocular mucocutaneous leishmaniasis with perforation of the anterior nasal septum: a rare differential diagnosis]. [PDF]
Burkhardt V +5 more
europepmc +1 more source
Towards Credible GHG Reporting: The Role of GHG Assurance and Assurance Providers in Firm Valuation
The demand for greenhouse gas (GHG) emissions disclosures is rising globally; yet, the credibility of such information remains uncertain when assurance is not mandated. Drawing on a sample of firms from 43 countries, this study examines the role of GHG assurance and the choice of assurance provider in the market value effects of GHG emissions.
Sudipta Bose +2 more
wiley +1 more source
From a Gene Mutation to Pathology and Targeted Therapy in a Patient with Therapy-resistant Porokeratosis. [PDF]
Möller M +4 more
europepmc +1 more source
Running towards: Labour market incentives for runaway slaves in the British Cape Colony, 1830–1838
Abstract Recent scholarship on slave escapes has increasingly emphasised economic motivation, but few studies have empirically investigated how market incentives influenced the decision‐making of enslaved individuals during transitions from coerced to wage labour.
Karl Bergemann +2 more
wiley +1 more source
Source: Karl Henckell: Gesammelte Werke. Erste kritische Ausgabe eigener Hand, Band 1: Buch des Lebens, Band 2: Buch des Kampfes, München: Müller, 1921.
Werron, Tobias +6 more
openaire +3 more sources
Evidence for Autoimmunity in the Pathogenesis of COVID-19-Induced Myocarditis. [PDF]
Tuvali O +4 more
europepmc +1 more source
Conventional tests, such as specific IgE (sIgE) or intradermal testing (IDT), are usually sufficient. Combining both tests increases sensitivity, while additional tests, like the basophil activation test (BAT), provide no further benefit for the majority of patients.
Lisa Arzt‐Gradwohl +8 more
wiley +1 more source
Symptomatic Left Main Coronary Artery Aneurysm With Intraluminal Thrombus. [PDF]
DiChiacchio L +4 more
europepmc +1 more source
Ligelizumab re‐treatment in CSU patients showed sustained efficacy and tolerability. Over 50% achieved symptom control (UAS7 ≤ 6) by Week 12; benefits maintained through Week 52. No new safety signals observed; aligns with prior PEARL trial outcomes. CSU, chronic spontaneous urticaria; mg, milligram; q4w, every 4 weeks; UAS, urticaria activity score ...
Ana M. Gimenez‐Arnau +22 more
wiley +1 more source

